Articles published by Cocrystal Pharma, Inc.
Cocrystal Pharma to Participate in Two Investor Conferences in November
November 02, 2022
Via GlobeNewswire
Tickers
COCP
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
October 26, 2022
Via GlobeNewswire
Tickers
COCP
Cocrystal Pharma to Present at the LD Micro Main Event XV
October 19, 2022
Via GlobeNewswire
Tickers
COCP
Cocrystal Pharma to Present CC-42344 Phase 1 Influenza A Data at the World Antiviral Congress 2022
October 13, 2022
Via GlobeNewswire
Tickers
COCP
Cocrystal Pharma Selects CDI-988 for Clinical Development as an Oral Treatment for COVID-19
October 11, 2022
Via GlobeNewswire
Tickers
COCP
Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference
October 05, 2022
Via GlobeNewswire
Tickers
COCP
Cocrystal Pharma Announces a 1-for-12 Reverse Stock Split
October 03, 2022
Via GlobeNewswire
Tickers
COCP
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.